Literature DB >> 14650824

Mechanisms of immune dysfunction in renal cell carcinoma.

Ithaar H Derweesh1, Charles S Tannenbaum, Patricia A Rayman, James H Finke.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 14650824     DOI: 10.1007/978-1-4615-0451-1_2

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


× No keyword cloud information.
  6 in total

1.  Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour.

Authors:  A Häne; M Bargetzi; E Hewer; M Bruehlmeier; A Khamis; U Roelcke
Journal:  J Neurol       Date:  2010-08-29       Impact factor: 4.849

Review 2.  Enhancing the efficacy of cancer vaccines in urologic oncology: new directions.

Authors:  Sergei Kusmartsev; Johannes Vieweg
Journal:  Nat Rev Urol       Date:  2009-09-08       Impact factor: 14.432

3.  Enhanced 15-lipoxygenase activity and elevated eicosanoid production in kidney tumor microenvironment contribute to the inflammation and immune suppression.

Authors:  Sergei Kusmartsev
Journal:  Oncoimmunology       Date:  2012-03-01       Impact factor: 8.110

4.  High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma.

Authors:  Sergei Kusmartsev; Elizabeth Kwenda; Paul R Dominguez-Gutierrez; Paul L Crispen; Padraic O'Malley
Journal:  J Kidney Cancer VHL       Date:  2022-04-16

Review 5.  Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review.

Authors:  Lu Zhang; Wen Zhang; Ziye Li; Shumeng Lin; Tiansheng Zheng; Bingjie Hao; Yaqin Hou; Yanfei Zhang; Kai Wang; Chenge Qin; Liduo Yue; Jing Jin; Ming Li; Lihong Fan
Journal:  J Exp Clin Cancer Res       Date:  2022-07-21

6.  Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning.

Authors:  Ignacio Durán; Daniel Castellano; Javier Puente; Lidia Martín-Couce; Esther Bello; Urbano Anido; José Manuel Mas; Luis Costa
Journal:  Oncotarget       Date:  2022-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.